{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:21:50Z","timestamp":1766067710019},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intrahepatic cholangiocarcinoma (iCCA) is a rare malignancy, recently classified in small duct and large duct morphological subtypes. Growing evidence suggests asbestos as a putative risk factor for iCCA, albeit no correlation between asbestos and iCCA morphology has been investigated so far. The aim of the present study was to assess the relationship between asbestos exposure and iCCA morphological subtype. Forty patients with surgically removed iCCA were prospectively enrolled: asbestos exposure was assessed according to the Italian National Mesothelioma Register questionnaire. From the surgical iCCA specimens the main histopathological variables were collected, including the small duct (sd-iCCA, 32 patients) and large duct subtypes (ld-iCCA, 8 patients). Five sd-iCCA cases had a definite\/probable occupational exposure to asbestos, while no cases of ld-iCCA were classified as being occupationally exposed (definite\/probable). Other kind of asbestos exposure (i.e. possible occupational, familial, environmental) were recorded in 16 sd-iCCA and 3 ld-iCCA. Cases with unlikely exposure to asbestos were 11 sd-iCCA (35.5%) and 5 ld-iCCA (62.5%). In conclusion, these findings seem to indicate that sd-iCCA might be more frequently associated to asbestos exposure rather than ld-iCCA, suggesting that asbestos fibres might represent a <jats:italic>parenchymal<\/jats:italic>, rather than a ductal risk factor for iCCA. This pilot study must be confirmed by further case\u2013control studies or large independent cohorts.<\/jats:p>","DOI":"10.1038\/s41598-023-27791-1","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T21:32:39Z","timestamp":1676323959000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study"],"prefix":"10.1038","volume":"13","author":[{"given":"Francesco","family":"Vasuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Deserti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo G.","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Tavolari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Relli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Palloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Frega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Curti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Cescon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"D\u2019Errico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"27791_CR1","volume-title":"WHO Classification of tumours Digestive System Tumours","author":"WHO","year":"2019","unstructured":"WHO. WHO Classification of tumours Digestive System Tumours 5th edn. (WHO, 2019).","edition":"5"},{"key":"27791_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle, J. W., Kelley, R. K., Nervi, B., Oh, D. Y. & Zhu, A. X. Biliary tract cancer. Lancet 397, 428\u2013444. https:\/\/doi.org\/10.1016\/S0140-6736(21)00153-7 (2021).","journal-title":"Lancet"},{"issue":"Suppl 1","key":"27791_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan, S. A., Tavolari, S. & Brandi, G. Cholangiocarcinoma: Epidemiology and risk factors. Liver. Int. 39(Suppl 1), 19\u201331. https:\/\/doi.org\/10.1111\/liv.14095 (2019).","journal-title":"Liver. Int."},{"key":"27791_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: The next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"27791_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cancergen.2020.10.001","volume":"248\u2013249","author":"G Brandi","year":"2020","unstructured":"Brandi, G. et al. Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos. Cancer. Genet. 248\u2013249, 57\u201362. https:\/\/doi.org\/10.1016\/j.cancergen.2020.10.001 (2020).","journal-title":"Cancer. Genet."},{"key":"27791_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1539\/joh.15-0170-OA","volume":"57","author":"K Yamada","year":"2015","unstructured":"Yamada, K., Kumagai, S., Kubo, S. & Endo, G. Chemical exposure levels in printing and coating workers with cholangiocarcinoma (third report). J. Occup. Health. 57, 565\u2013571. https:\/\/doi.org\/10.1539\/joh.15-0170-OA (2015).","journal-title":"J. Occup. Health."},{"key":"27791_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/oemed-2017-104603","volume":"75","author":"A Farioli","year":"2018","unstructured":"Farioli, A. et al. Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries. Occup. Environ. Med. 75, 191\u2013198. https:\/\/doi.org\/10.1136\/oemed-2017-104603 (2018).","journal-title":"Occup. Environ. Med."},{"key":"27791_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s10552-013-0167-3","volume":"24","author":"G Brandi","year":"2013","unstructured":"Brandi, G. et al. Asbestos: A hidden player behind the cholangiocarcinoma increase? Findings from a case-control analysis. Cancer. Causes. Control. 24, 911\u2013918. https:\/\/doi.org\/10.1007\/s10552-013-0167-3 (2013).","journal-title":"Cancer. Causes. Control."},{"key":"27791_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.micron.2017.12.001","volume":"105","author":"A Croce","year":"2018","unstructured":"Croce, A. et al. Asbestos fibre burden in gallbladder: A case study. Micron 105, 98\u2013104. https:\/\/doi.org\/10.1016\/j.micron.2017.12.001 (2018).","journal-title":"Micron"},{"key":"27791_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/MEG.0000000000000357","volume":"27","author":"F Grosso","year":"2015","unstructured":"Grosso, F. et al. Asbestos fibers in the gallbladder of patients affected by benign biliary tract diseases. Eur. J. Gastroenterol. Hepatol. 27, 860\u2013864. https:\/\/doi.org\/10.1097\/MEG.0000000000000357 (2015).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"27791_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/0300891619839305","volume":"105","author":"F Grosso","year":"2019","unstructured":"Grosso, F. et al. Asbestos fiber identification in liver from cholangiocarcinoma patients living in an asbestos polluted area: A preliminary study. Tumori 105, 404\u2013410. https:\/\/doi.org\/10.1177\/0300891619839305 (2019).","journal-title":"Tumori"},{"key":"27791_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1289\/ehp.8353121","volume":"53","author":"PM Cook","year":"1983","unstructured":"Cook, P. M. Review of published studies on gut penetration by ingested asbestos fibers. Environ. Health. Perspect. 53, 121\u2013130. https:\/\/doi.org\/10.1289\/ehp.8353121 (1983).","journal-title":"Environ. Health. Perspect."},{"key":"27791_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-069X-7","volume":"7","author":"G Miserocchi","year":"2008","unstructured":"Miserocchi, G., Sancini, G., Mantegazza, F. & Chiappino, G. Translocation pathways for inhaled asbestos fibers. Environ. Health. 7, 4. https:\/\/doi.org\/10.1186\/1476-069X-7 (2008).","journal-title":"Environ. Health."},{"key":"27791_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s1567-5769(01)00172-2","volume":"2","author":"CB Manning","year":"2002","unstructured":"Manning, C. B., Vallyathan, V. & Mossman, B. T. Diseases caused by asbestos: Mechanisms of injury and disease development. Int. Immunopharmacol. 2, 191\u2013200. https:\/\/doi.org\/10.1016\/s1567-5769(01)00172-2 (2002).","journal-title":"Int. Immunopharmacol."},{"key":"27791_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2486\/indhealth.40.383","volume":"40","author":"C Bianchi","year":"2002","unstructured":"Bianchi, C., Ramani, L. & Bianchi, T. Concurrent malignant mesothelioma of the pleura and hepatocellular carcinoma in the same patient: A report of five cases. Ind. Health. 40, 383\u2013387. https:\/\/doi.org\/10.2486\/indhealth.40.383 (2002).","journal-title":"Ind. Health."},{"key":"27791_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","volume":"27","author":"JY Liau","year":"2014","unstructured":"Liau, J. Y. et al. Morphological subclassification of intrahepatic cholangiocarcinoma: Etiological, clinicopathological, and molecular features. Mod. Pathol. 27, 1163\u20131173. https:\/\/doi.org\/10.1038\/modpathol.2013.241 (2014).","journal-title":"Mod. Pathol."},{"key":"27791_CR17","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.4254\/wjh.v12.i12.1148","volume":"12","author":"KS Ahn","year":"2020","unstructured":"Ahn, K. S. & Kang, K. J. Molecular heterogeneity in intrahepatic cholangiocarcinoma. World. J. Hepatol. 12, 1148\u20131157. https:\/\/doi.org\/10.4254\/wjh.v12.i12.1148 (2020).","journal-title":"World. J. Hepatol."},{"key":"27791_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/cells9020421","volume":"9","author":"G Brandi","year":"2020","unstructured":"Brandi, G. & Tavolari, S. Asbestos and intrahepatic cholangiocarcinoma. Cells 9, 421. https:\/\/doi.org\/10.3390\/cells9020421 (2020).","journal-title":"Cells"},{"key":"27791_CR19","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/hep.510300614","volume":"30","author":"ND Theise","year":"1999","unstructured":"Theise, N. D. et al. The canals of Hering and hepatic stem cells in humans. Hepatology 30, 1425\u20131433. https:\/\/doi.org\/10.1002\/hep.510300614 (1999).","journal-title":"Hepatology"},{"key":"27791_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbagen.2016.09.031","volume":"1861","author":"T Padmore","year":"2017","unstructured":"Padmore, T., Stark, C., Turkevich, L. A. & Champion, J. A. Quantitative analysis of the role of fiber length on phagocytosis and inflammatory response by alveolar macrophages. Biochim. Biophys. Acta. Gen. Subj. 1861, 58\u201367. https:\/\/doi.org\/10.1016\/j.bbagen.2016.09.031 (2017).","journal-title":"Biochim. Biophys. Acta. Gen. Subj."},{"key":"27791_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1054\/bjoc.2000.1161","volume":"83","author":"C Magnani","year":"2000","unstructured":"Magnani, C. et al. Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br. J. Cancer. 83, 104\u2013111. https:\/\/doi.org\/10.1054\/bjoc.2000.1161 (2000).","journal-title":"Br. J. Cancer."},{"key":"27791_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.5271\/sjweh.3895","volume":"46","author":"A Marinaccio","year":"2020","unstructured":"Marinaccio, A. et al. Association between asbestos exposure and pericardial and tunica vaginalis testis malignant mesothelioma: A case-control study and epidemiological remarks. Scand. J. Work. Environ. Health. 46, 609\u2013617. https:\/\/doi.org\/10.5271\/sjweh.3895 (2020).","journal-title":"Scand. J. Work. Environ. Health."},{"key":"27791_CR23","volume-title":"Guidelines for the identification of malignant mesothelioma cases by Regional Operative Centres and transmission to ISPESL","author":"M Nesti","year":"2003","unstructured":"Nesti, M. et al. Guidelines for the identification of malignant mesothelioma cases by Regional Operative Centres and transmission to ISPESL (Monografia ISPESL, 2003)."},{"key":"27791_CR24","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1097\/PAS.0000000000001118","volume":"42","author":"CS Sigel","year":"2018","unstructured":"Sigel, C. S. et al. Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns. Am. J. Surg. Pathol. 42, 1334\u20131345. https:\/\/doi.org\/10.1097\/PAS.0000000000001118 (2018).","journal-title":"Am. J. Surg. Pathol."},{"key":"27791_CR25","volume-title":"Statistical Methods in Cancer Research,","author":"NE Breslow","year":"1980","unstructured":"Breslow, N. E. & Day, N. E. Statistical Methods in Cancer Research, Vol. 1 (International Agency for Research on Cancer, 1980)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27791-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27791-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27791-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T21:36:37Z","timestamp":1676324197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27791-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["27791"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-27791-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2580"}}